ClinicalTrials.gov
public full text
Public Domain
Recombinant Interleukin-7 (CYT107) to Restore Absolute Lymphocyte Counts in Sepsis Patients
This phase II randomized study will assess the effect of receiving IV recombinant human IL-7 (CYT107) versus placebo in lymphopenic sepsis patients The aim is to confirm the immune cell reconstitution observed in other studies and other patient populations among which the IRIS-7 A\&B study which was conducted in the same patient population.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients#832996
- Inflammatory Anemia Associated Parameters in Septic Patients#902273
- Efficacy of Thymosin Alpha 1 on Improving Monocyte Function for Sepsis#912001
- Intravenous Immune Globulin (IVIG) Treatment Protocol in Kidney Transplant Patients#860424
- Urine Interleukin-37 as a Biomarker of Mortality Risk in Patients With Sepsis#844026
Record · ID 837997
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive